These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 29581249

  • 41. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
    Yu X, Meng X, Xu M, Zhang X, Zhang Y, Ding G, Huang S, Zhang A, Jia Z.
    EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
    [Abstract] [Full Text] [Related]

  • 42. Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways.
    Long G, Chen H, Wu M, Li Y, Gao L, Huang S, Zhang Y, Jia Z, Xia W.
    Front Pharmacol; 2020 Oct; 11():1191. PubMed ID: 32848792
    [Abstract] [Full Text] [Related]

  • 43. Radioprotective effects of roxadustat (FG-4592) in haematopoietic system.
    Zhang P, Du J, Zhao H, Cheng Y, Dong S, Yang Y, Li B, Gao F, Sun X, Cai J, Liu C.
    J Cell Mol Med; 2019 Jan; 23(1):349-356. PubMed ID: 30334352
    [Abstract] [Full Text] [Related]

  • 44. Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation.
    Xie RY, Fang XL, Zheng XB, Lv WZ, Li YJ, Ibrahim Rage H, He QL, Zhu WP, Cui TX.
    Biomed Pharmacother; 2019 Oct; 118():109175. PubMed ID: 31351423
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
    Liu XQ, Jin J, Li Z, Jiang L, Dong YH, Cai YT, Wu MF, Wang JN, Ma TT, Wen JG, Liu MM, Li J, Wu YG, Meng XM.
    Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
    [Abstract] [Full Text] [Related]

  • 47. The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia.
    Su K, Li Z, Yu Y, Zhang X.
    Drug Discov Today; 2020 Jul; 25(7):1262-1269. PubMed ID: 32380083
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Roxadustat in the treatment of anaemia in chronic kidney disease.
    Del Vecchio L, Locatelli F.
    Expert Opin Investig Drugs; 2018 Jan; 27(1):125-133. PubMed ID: 29254377
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
    Tsogbadrakh B, Ryu H, Ju KD, Lee J, Yun S, Yu KS, Kim HJ, Ahn C, Oh KH.
    Biochem Biophys Res Commun; 2019 Feb 12; 509(3):680-686. PubMed ID: 30616891
    [Abstract] [Full Text] [Related]

  • 55. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney.
    Rosenberger C, Rosen S, Shina A, Frei U, Eckardt KU, Flippin LA, Arend M, Klaus SJ, Heyman SN.
    Nephrol Dial Transplant; 2008 Nov 12; 23(11):3472-8. PubMed ID: 18515655
    [Abstract] [Full Text] [Related]

  • 56. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
    Oh SM, Park G, Lee SH, Seo CS, Shin HK, Oh DS.
    BMC Complement Altern Med; 2017 Dec 19; 17(1):544. PubMed ID: 29258482
    [Abstract] [Full Text] [Related]

  • 57. Yi-Shen-Xie-Zhuo formula alleviates cisplatin-induced AKI by regulating inflammation and apoptosis via the cGAS/STING pathway.
    Qi J, Luo Q, Zhang Q, Wu M, Zhang L, Qin L, Xue Q, Nie X.
    J Ethnopharmacol; 2023 Jun 12; 309():116327. PubMed ID: 36889420
    [Abstract] [Full Text] [Related]

  • 58. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
    Meng XM, Li HD, Wu WF, Ming-Kuen Tang P, Ren GL, Gao L, Li XF, Yang Y, Xu T, Ma TT, Li Z, Huang C, Zhang L, Lv XW, Li J.
    Lab Invest; 2018 Jan 12; 98(1):79-94. PubMed ID: 29200200
    [Abstract] [Full Text] [Related]

  • 59. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
    Yang Q, Zang HM, Xing T, Zhang SF, Li C, Zhang Y, Dong YH, Hu XW, Yu JT, Wen JG, Jin J, Li J, Zhao R, Ma TT, Meng XM.
    Phytomedicine; 2021 May 12; 85():153541. PubMed ID: 33773190
    [Abstract] [Full Text] [Related]

  • 60. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
    Chen RL, Ogunshola OO, Yeoh KK, Jani A, Papadakis M, Nagel S, Schofield CJ, Buchan AM.
    J Neurochem; 2014 Oct 12; 131(2):177-89. PubMed ID: 24974727
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.